Dendritic cell immunotherapy followed by cART interruption during HIV-1 infection induces plasma protein markers of cellular immunity and neutrophil recruitment

Autor: Ham, H.J. van den, Cooper, J.D., Tomasik, J., Bahn, S., Aerts, J.L., Osterhaus, A., Gruters, R.A., Andeweg, A.C., Goede, A.L. de, Lacorb, P., Thielemans, K.

Publikováno v: PLoS One, 13
PLoS ONE
PLoS ONE, Vol 13, Iss 2, p e0192278 (2018)
PLoS One (online), 13(2):e0192278. Public Library of Science
PLoS One, 13, 2

Contains fulltext : 190926.pdf (Publisher’s version ) (Open Access) OBJECTIVES: To characterize the host response to dendritic cell-based immunotherapy and subsequent combined antiretroviral therapy (cART) interruption in HIV-1-infected individuals

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd951b3bd34ac3fe5e6a00c1abe2db52
http://hdl.handle.net/2066/190926